08048035968
Herduo 250 Tablet Good Quality to UK - Liverpool | Phoenix Exim | Trusted Exporter

1. General Information

  • Brand: Herduo 250 mg Tablet
  • Generic/Active ingredient: Lapatinib
  • Strength: 250 mg
  • Dosage form: Oral tablet
  • Therapeutic category: Anti-cancer / targeted cancer therapy
  • Drug class: Tyrosine kinase inhibitor
  • Manufacturer: Natco Pharma Ltd.
  • Primary indication: Certain HER2-positive advanced or metastatic breast cancers
  • Prescription status: Prescription medicine

2. Product Information

Each Herduo 250 mg tablet contains lapatinib equivalent to 250 mg of lapatinib free base. Lapatinib is a targeted therapy that inhibits intracellular tyrosine kinase activity associated with HER2 (ErbB2) and EGFR (ErbB1) receptors.

Herduo is available in different pack sizes, including 30-tablet and 150-tablet packs in India.

3. Uses of Herduo 250 mg

Herduo is used for specific breast cancer treatment plans, including:

  • HER2-positive advanced or metastatic breast cancer
  • HER2-positive advanced/metastatic disease in patients who have previously received certain treatments, when prescribed with capecitabine
  • Certain HER2-positive, hormone-receptor-positive metastatic breast cancers, where hormonal therapy is appropriate, in combination with letrozole
  • Other combinations may be appropriate for particular patients under an oncologist's direction.

4. Benefits of Herduo 250 mg

The main potential benefit is its targeted action against cancer-related signaling pathways.

  • Helps inhibit signaling through HER2 and EGFR.
  • Can slow the growth and proliferation of certain HER2-overexpressing cancer cells.
  • Provides an oral targeted-treatment option for appropriately selected patients.
  • May be used with other anti-cancer therapies to form a personalized treatment regimen.

Important: Herduo is not a general cancer medicine for every type of breast cancer. Its suitability depends on the cancer's HER2 status, previous treatments, overall health, and the oncologist's treatment plan.

5. Side Effects of Herduo 250 mg

Like other anti-cancer medicines, Herduo can cause side effects. Possible adverse effects include:

  • Diarrhea
  • Nausea
  • Vomiting
  • Fatigue or weakness
  • Rash
  • Loss of appetite
  • Indigestion
  • Headache
  • Mouth sores
  • Dry skin
  • Hair loss
  • Muscle pain
  • Hypersensitivity/allergic reactions

Some potentially serious effects include severe diarrhea, liver toxicity, reduced left-ventricular ejection fraction/heart problems, and embryo-fetal toxicity.

6. Common Side Effects

The commonly reported side effects may include:

  1. Diarrhea
  2. Nausea
  3. Fatigue
  4. Skin rash
  5. Vomiting
  6. Loss of appetite
  7. Indigestion
  8. Headache
  9. Weakness
  10. Dry skin

Patients should tell their doctor if side effects are persistent, severe, or worsening.

7. How to Use Herduo 250 mg

Herduo should be taken exactly as prescribed by the oncologist.

  • Swallow the tablet whole with water.
  • Do not crush, chew, or break the tablet.
  • Take it at approximately the same time each day.
  • Lapatinib should generally be taken at least 1 hour before or 1 hour after food.
  • The prescribed number of tablets depends on the treatment regimen.
  • Do not change the dose or stop treatment without consulting your oncologist.
  • If you miss a dose, do not double the next dose unless your doctor specifically instructs you otherwise.

For example, the official product information describes a 1,250 mg once-daily regimen (five 250 mg tablets) when used with capecitabine for a particular HER2-positive metastatic breast-cancer indication. However, the appropriate regimen varies by indication and combination therapy, so patients should follow their individual prescription rather than use this example as a self-dosing instruction.

8. How Herduo 250 mg Works

Herduo contains lapatinib, a tyrosine kinase inhibitor.

Lapatinib blocks the intracellular kinase activity of HER2/ErbB2 and EGFR/ErbB1 receptors. These receptors can send signals that encourage cancer-cell growth and survival. By inhibiting these signaling pathways, lapatinib can reduce cancer-cell proliferation and survival in susceptible HER2-overexpressing tumors.

9. Safety Advice

Prescription use: Herduo should only be used under qualified medical supervision.

Heart: Inform your doctor about existing heart disease. Lapatinib can affect cardiac function, and monitoring may be required.

Liver: Lapatinib can cause liver toxicity. Seek medical attention for symptoms such as yellowing of the skin/eyes, dark urine, unusual itching, abdominal pain, or other signs of liver problems.

Diarrhea: Severe diarrhea can occur. Persistent or severe diarrhea should be reported promptly because dehydration and other complications can occur.

Pregnancy: Lapatinib can cause embryo-fetal harm. Women who are pregnant, planning pregnancy, or capable of becoming pregnant should discuss appropriate contraception and pregnancy precautions with their doctor.

Breastfeeding: Discuss breastfeeding with the treating doctor before starting treatment.

Other medicines: Tell your doctor about all prescription medicines, OTC medicines, vitamins, and herbal products because lapatinib has clinically important drug interactions.

Monitoring: Depending on the treatment plan, doctors may monitor liver function and cardiac function during therapy.

10. FAQs

Q1. What is Herduo 250 mg used for?
Herduo 250 mg is used for certain HER2-positive advanced or metastatic breast cancers, generally as part of a combination treatment prescribed by an oncologist.

Q2. What is the generic name of Herduo 250 mg?
The active ingredient is lapatinib.

Q3. Is Herduo a chemotherapy medicine?
Herduo is an oral targeted anti-cancer therapy, specifically a tyrosine kinase inhibitor. It is different from traditional cytotoxic chemotherapy.

Q4. Can Herduo be taken with other cancer medicines?
Yes. Depending on the indication, it may be prescribed with medicines such as capecitabine, letrozole, or trastuzumab. The combination must be determined by the treating oncologist.

Q5. Should Herduo be taken with food?
Lapatinib is generally taken at least one hour before or one hour after food.

Q6. Can I stop Herduo if I feel better?
No. Cancer treatment should not be stopped or changed without consulting the oncologist.

Q7. Can Herduo affect the liver?
Yes. Liver toxicity has been reported and can sometimes be serious. Liver-function monitoring may be required.

Q8. Can Herduo cause diarrhea?
Yes. Diarrhea is one of the important adverse effects associated with lapatinib. Severe or persistent diarrhea requires medical attention.

Q9. Is Herduo 250 mg available in India?
Yes. Herduo 250 is an Indian lapatinib brand and is listed in Indian pharmaceutical sources.

Q10. Is a prescription required?
Herduo is a prescription anti-cancer medicine and should be supplied and used according to applicable medical and pharmaceutical regulations.

11. Substitutes for Herduo 250 mg

Herduo 250 mg contains lapatinib, so potential therapeutic alternatives may include other lapatinib 250 mg brands, depending on availability and local regulations. Indian sources list brands such as Hertab, Herlapsa, Lapadem/Lapatem, LapaHope and other lapatinib products.

However, a substitute should not be selected solely by brand name. The oncologist or pharmacist should confirm the active ingredient, strength, formulation, indication, and suitability before substitution.

12. SEO Keywords

Primary keywords:

  • Herduo 250 mg Tablet
  • Herduo 250 mg
  • Herduo 250 Lapatinib Tablet
  • Lapatinib 250 mg Tablet
  • Herduo Lapatinib 250 mg
  • Herduo 250 mg manufacturer
  • Herduo 250 mg supplier
  • Herduo 250 mg exporter
  • Herduo 250 mg medicine exporter from India
  • Herduo 250 mg tablets from India

Long-tail B2B / export keywords:

  • Buy Herduo 250 mg tablets from India
  • Herduo 250 mg tablet supplier from Nagpur India
  • Herduo 250 mg tablet exporter from Nagpur India
  • Lapatinib 250 mg tablet exporter India
  • Herduo 250 mg wholesale supplier India
  • Herduo 250 mg pharmaceutical exporter
  • Herduo 250 mg medicine supplier India
  • Herduo 250 mg anti cancer medicine supplier
  • Herduo 250 mg breast cancer medicine exporter
  • Herduo 250 mg tablets international supplier
  • Herduo 250 mg tablets export from India
  • Lapatinib 250 mg wholesale supplier India
  • Lapatinib 250 mg anti cancer medicine exporter
  • HER2 positive breast cancer medicine supplier
  • Herduo 250 mg supplier to USA
  • Herduo 250 mg supplier to UK
  • Herduo 250 mg supplier to Australia
  • Herduo 250 mg supplier to Canada
  • Herduo 250 mg supplier to Singapore
  • Herduo 250 mg supplier to South Korea
  • Herduo 250 mg supplier to UAE
Aug 17th, 2026 3:28 PM

Keywords